The Partnership for Research on Ebola Virus in Liberia (PREVAIL) has begun its fourth sub-study in communities once affected by the Ebola Virus Disease with participants from 18 years old.
A dialogue on PREVAIL’s sub-study known as PREVAIL-4 was held recently with nearly 100 men (EVD survivors and close contacts) in attendance in Paynesville, outside Monrovia.
PREVAIL-4 is about the conduct of a clinical research through testing of the semen of men who came in contact with the disease to detect the presence or absence of EVD samples that could be responsible for the complications they are experiencing today.
Giving details about the sub-study, PREVAIL’s head of social mobilization, community engagement, outreach and awareness, Mr. Bartholomew Wilson said it is important for Ebola male survivors to enroll in the study as it would help them know their own post Ebola status and get proper medical care with no cost attached.
“It is good for survivors to take advantage of this sub-study because its life span is for 6 months and we have covered nearly two months,” Mr. Wilson said.
He said men going for the test at the John F. Kennedy Memorial Hospital should stop taking in alcoholic beverages and smoking.
PREVAIL’s head of mobilization further explained that after an individual is proven positive of having samples of the EVD, within 42 days he will be enrolled in the Ebola Natural History Study which covers vaccine study.
“Another is the neurological sub-study that is about testing the balance of an EVD survivor’s brain chemistry.
“We write letters or display certain objects and ask a survivor to identify. In case he or she does not give the right information as a response in relation to the question asked we enroll the person in the Ebola Natural History Study,” Mr. Wilson explained.
He said PREVAIL has six Liberians that are presently studying health courses at Harvard University and over 300 others have secured jobs and are now helping their households.
Speaking earlier, the secretary general of the SKD Community, Mr. James H. Adams said Ebola would remain a national common enemy that everyone needs to be on the alert to fight against.
“Let us not repeat the mistakes of the past such as hiding sensitive health information that led to the death of thousands of our fellow compatriots when Ebola took hold of our country,” Mr. Adams said.
He called on EVD male survivors to go to the John F. Kennedy Medical Center to form part of the study so as to avert future recurrence of EVD along with its many complications.